| Year |
Citation |
Score |
| 2012 |
Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT, Wang JX, Cheng L, Mohanan S, Buckley MR, Cohen I, Nikitin AY, Williams RM, Gourdon D, et al. Implanted adipose progenitor cells as physicochemical regulators of breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 109: 9786-91. PMID 22665775 DOI: 10.1073/Pnas.1121160109 |
0.589 |
|
| 2010 |
Cheng L, Zhou Z, Flesken-Nikitin A, Toshkov IA, Wang W, Camps J, Ried T, Nikitin AY. Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency. Oncogene. 29: 5700-11. PMID 20676140 DOI: 10.1038/Onc.2010.300 |
0.549 |
|
| 2010 |
Liu K, Cheng L, Flesken-Nikitin A, Huang L, Nikitin AY, Pauli BU. Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation. Developmental Biology. 346: 11-24. PMID 20624380 DOI: 10.1016/J.Ydbio.2010.07.001 |
0.551 |
|
| 2010 |
Li B, Antonyak MA, Druso JE, Cheng L, Nikitin AY, Cerione RA. EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation. Proceedings of the National Academy of Sciences of the United States of America. 107: 1408-13. PMID 20080707 DOI: 10.1073/Pnas.0907907107 |
0.598 |
|
| 2010 |
Cheng L, Ramesh AV, Flesken-Nikitin A, Choi J, Nikitin AY. Mouse models for cancer stem cell research. Toxicologic Pathology. 38: 62-71. PMID 19920280 DOI: 10.1177/0192623309354109 |
0.571 |
|
| 2008 |
Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N. Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proceedings of the National Academy of Sciences of the United States of America. 105: 7546-51. PMID 18495924 DOI: 10.1073/Pnas.0709981105 |
0.532 |
|
| Show low-probability matches. |